These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 99192)

  • 1. A novel nutritional approach to probe the molecular basis of behavior.
    Abell CW; Fritz PR; Poffenbarger PL; Adams PM; Barratt ES
    Birth Defects Orig Artic Ser; 1978; 14(5):323-32. PubMed ID: 99192
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo effects of phenylalanine ammonia-lyase.
    Roberts J; Schmid FA; Takai K
    Cancer Treat Rep; 1976 Mar; 60(3):261-3. PubMed ID: 1260781
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical properties and immunogenicity of L-phenylalanine ammonia-lyase: effects on tumor-bearing mice.
    Shen RS; Fritz RR; Abell CW
    Cancer Treat Rep; 1979 Jun; 63(6):1063-8. PubMed ID: 466645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylalanine ammonia lyase in the management of phenylketonuria: the relationship between ingested cinnamate and urinary hippurate in humans.
    Hoskins JA; Gray J
    Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):275-82. PubMed ID: 7071414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multitubular reactors with immobilized L-phenylalanine ammonia-lyase for use in extracorporeal shunts.
    Kalghatgi K; Horváth C; Ambrus CM
    Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):551-61. PubMed ID: 7384643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nutritional habits of children with portosystemic anastomoses--effects on serum ammonia and amino acid level].
    Cario RW; Glende M; Grossmann P; Huth M; Koch R; Lampe D; Läuter E; Prien F
    Kinderarztl Prax; 1981 May; 49(5):245-51. PubMed ID: 7253412
    [No Abstract]   [Full Text] [Related]  

  • 7. Total-body radiation suppression of the clearance of phenylalanine ammonia-lyase from mouse plasma.
    Shen RS; Jenkins VK; Fritz RR; Briner RP; Abell CW
    J Reticuloendothel Soc; 1978 Mar; 23(3):167-75. PubMed ID: 650637
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo safety of hollow fiber enzyme-reactors with immobilized phenylalanine ammonia-lyase in a large animal model for phenylketonuria.
    Ambrus CM; Sharma SD; Horváth C; Kalghatgi K; Anthone S; Ambrus JL; Cooley C; Mirand EA
    J Pharmacol Exp Ther; 1983 Mar; 224(3):598-602. PubMed ID: 6681841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of phenylalanine ammonia-lyase from normal and tumor-bearing mice.
    Shen RS; Fritz RR; Abell CW
    Cancer Res; 1977 Apr; 37(4):1051-6. PubMed ID: 265185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylalanine ammonia-lyase immobilized in microcapsules for the depletion of phenylalanine in plasma in phenylketonuric rat model.
    Bourget L; Chang TM
    Biochim Biophys Acta; 1986 Oct; 883(3):432-8. PubMed ID: 3756210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of rapid depletion of phenylalanine and tyrosine on sleep and behavior.
    Barratt ES; Adams PM; Poffenbarger PL; Fritz RR; Abell CW
    Pharmacol Biochem Behav; 1976 Jul; 5(1):47-53. PubMed ID: 825881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of immobilized L-phenylalanine ammonia-lyase in tubular form for depletion of L-phenylalanine.
    Pedersen H; Horvath C; Ambrus CM
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):559-69. PubMed ID: 674832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro evaluation of the chemotherapeutic potency of phenylalanine ammonia-lyase.
    Abell CW; Hodgins DS; Stith WJ
    Cancer Res; 1973 Oct; 33(10):2529-32. PubMed ID: 4517735
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical basis for nutritional management of preterm infants.
    Räihä NC
    Pediatrics; 1974 Feb; 53(2):147-56. PubMed ID: 4149571
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM; Yellin TO
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phenylalanine ammonia-lyase of pigmented yeasts].
    Mushi NIu; Kupletskaia MB; Bab'eva IP; Egorov NS
    Mikrobiologiia; 1980; 49(2):269-73. PubMed ID: 7393004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of phenylalanine in the blood of phenylketonuric patients using a PAL-enzyme reactor. An in vitro study.
    Ambrus CM; Horváth C; Kalghatgi K; Clowsley M; Huzella C; Warner R; Ambrus JL; Cooley CM; Mirand EA
    Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):105-11. PubMed ID: 7122995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral contingencies involved in drug-induced neurotransmitter turnover changes.
    Dworkin SI; Smith JE
    NIDA Res Monogr; 1986; 74():90-106. PubMed ID: 2892137
    [No Abstract]   [Full Text] [Related]  

  • 19. 1-Amino-2-phenylethylphosphonic acid: an inhibitor of L-phenylalanine ammonia-lyase in vitro.
    Janas KM; Filipiak A; Kowalik J; Mastalerz P; Knypl JS
    Acta Biochim Pol; 1985; 32(2):131-43. PubMed ID: 4036447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Control of L-phenylalanine ammonia-lyase activity and red pigment level in higher plants by 1-amino-2-phenylethylphosphonic acid].
    Janas K
    Postepy Biochem; 1989; 35(1-2):155-61. PubMed ID: 2699027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.